Yes, Graves’ disease is an autoimmune disease. It is the most common cause of hyperthyroidism, affecting roughly 1% to 2% of the population, and it results from the immune system producing antibodies that directly stimulate the thyroid gland to overproduce hormones. Women are about five times more likely to develop it than men.
How the Immune System Causes Graves’ Disease
In a healthy body, the pituitary gland releases thyroid-stimulating hormone (TSH) to tell the thyroid how much hormone to make. In Graves’ disease, the immune system produces antibodies that mimic TSH by binding to the same receptor on thyroid cells. These stimulating antibodies activate the same signaling pathways TSH uses, triggering thyroid cells to grow and produce excess thyroid hormone. But unlike TSH, which is regulated by a feedback loop, these antibodies aren’t subject to any off switch. The thyroid keeps getting the signal to produce more, regardless of how much hormone is already circulating.
Three types of antibodies targeting the TSH receptor have been identified in people with autoimmune thyroid disease: stimulating antibodies (which drive hyperthyroidism), blocking antibodies (which can cause hypothyroidism), and so-called cleavage antibodies that target a different part of the receptor. The stimulating variety is what defines Graves’ disease, and modern blood tests can detect these antibodies with 97% sensitivity and 99% specificity.
What Triggers the Immune System to Attack
Genetics plays the dominant role. Studies estimate that genetic factors account for about 79% of the risk for developing Graves’ disease, with environmental factors making up the remaining 21%. Around 70% of the genes linked to autoimmune thyroid disorders are involved in T-cell function, the branch of the immune system responsible for coordinating attacks on perceived threats.
On the environmental side, several triggers have been identified. Smoking increases risk, as does excess iodine intake, vitamin D deficiency, and selenium deficiency. Stress is a well-recognized precipitating factor. Hepatitis C infection has been linked to thyroid autoimmunity, and patients treated with interferon-alpha for hepatitis C develop Graves’ disease at higher rates. Estrogen also appears to play a role, which helps explain the strong female predominance.
Symptoms of Graves’ Disease
Because excess thyroid hormone speeds up nearly every system in your body, symptoms tend to be widespread. The most common include rapid or irregular heartbeat, unintentional weight loss, heat intolerance, tremor in the hands, anxiety and irritability, difficulty sleeping, and frequent bowel movements. Many people also notice an enlarged thyroid (goiter) visible or palpable at the front of the neck.
About 27% of people with Graves’ disease develop thyroid eye disease, a condition where the same autoimmune process affects the tissues behind the eyes. Immune cells called CD34+ fibroblasts infiltrate the eye socket, releasing inflammatory chemicals that cause the muscles and fat around the eyes to swell. This leads to bulging eyes, double vision, eye pain, and in severe cases, vision loss. In 85% of affected patients, eye symptoms appear within 18 months of the Graves’ diagnosis. Smoking significantly worsens the risk and severity of thyroid eye disease.
Rarely, Graves’ disease causes a skin condition called pretibial myxedema, where the skin on the shins becomes reddish, thick, and rough in texture. It can also appear on the tops of the feet. Most cases are mild and painless.
How Graves’ Disease Is Diagnosed
Diagnosis starts with a blood test measuring TSH. In Graves’ disease, TSH is suppressed to very low levels because the pituitary gland senses all the excess thyroid hormone and stops sending its own signal. If TSH is low, the next step is measuring free T4 and free T3 (the active thyroid hormones). Suppressed TSH with elevated free T4 or free T3 confirms hyperthyroidism.
To distinguish Graves’ from other causes of hyperthyroidism, like an inflamed thyroid (thyroiditis) or a thyroid nodule producing excess hormone, doctors test for TSH receptor antibodies. A ratio of T3 to T4 greater than a certain threshold also points toward Graves’ rather than thyroiditis. A radioactive iodine uptake scan can provide additional confirmation: in Graves’ disease, the entire thyroid takes up iodine at a high rate, while in thyroiditis, uptake is low.
Treatment Options
There are three main approaches to treating Graves’ disease: antithyroid medications, radioactive iodine therapy, and surgery. The right choice depends on the severity of your symptoms, whether you have thyroid eye disease, your age, and whether you’re pregnant or planning to become pregnant.
Antithyroid medications work by reducing the thyroid’s ability to produce new hormone. Methimazole is the preferred first-line drug for most people. Propylthiouracil (PTU) is generally reserved for the first trimester of pregnancy, because methimazole can cause fetal developmental problems, while PTU carries a black box warning for potential liver failure. Both drugs carry a small risk (0.2% to 0.5%) of a dangerous drop in white blood cells. These medications can be taken for 12 to 18 months, after which about 40% to 50% of patients go into remission. The rest will relapse and typically need definitive treatment.
Radioactive iodine therapy involves swallowing a capsule that delivers radiation specifically to thyroid cells, gradually destroying enough tissue to stop hormone overproduction. The first dose succeeds about 81% of the time, and the overall success rate with additional doses reaches 90%. The trade-off is that most people eventually become hypothyroid and need to take thyroid hormone replacement for life. A small number of patients (about 0.7%) experience worsening eye disease after radioactive iodine, so this option is used cautiously in people who already have significant thyroid eye disease.
Thyroidectomy, the surgical removal of the thyroid, provides the most definitive resolution. There is no recurrence of Graves’ disease after total thyroidectomy, and no worsening of eye disease has been observed in surgical patients. Operative complications are higher than with radioactive iodine, but they tend to be temporary. Like radioactive iodine, surgery results in permanent hypothyroidism requiring daily thyroid hormone pills.
Thyroid Storm: A Rare but Serious Complication
Thyroid storm is a life-threatening escalation of hyperthyroidism that can occur in people with uncontrolled Graves’ disease, often triggered by infection, surgery, or stopping medications abruptly. Symptoms include very high fever, heart rate above 130, confusion or agitation progressing to delirium or coma, nausea and vomiting, and sometimes heart failure. Even with modern treatment, mortality ranges from 8% to 25%. Left untreated, it is fatal. This is why managing Graves’ disease promptly matters, even when symptoms feel manageable.